CBD tested in infants with rare, severe seizure disorders
Disease control
Terminated
This study aimed to test the safety and effectiveness of a cannabidiol (CBD) oral solution in babies under 2 years old with severe, hard-to-control epilepsy syndromes. It was designed to see if adding CBD to their current medications could help reduce their seizures. The study wa…
Phase: PHASE3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC